Your browser doesn't support javascript.
loading
Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up.
Horne, Anne M; Mihov, Borislav; Reid, Ian R.
Afiliação
  • Horne AM; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
  • Mihov B; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
  • Reid IR; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. i.reid@auckland.ac.nz.
Calcif Tissue Int ; 105(1): 107-108, 2019 07.
Article em En | MEDLINE | ID: mdl-31087124
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ósseas Metabólicas / Densidade Óssea / Denosumab / Ácido Zoledrônico / Anticorpos Monoclonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ósseas Metabólicas / Densidade Óssea / Denosumab / Ácido Zoledrônico / Anticorpos Monoclonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article